EUCTR2005-003279-18-NO进行中（未招募）1 期
HLH-2004. Hemophagocytic Lymphohistiocytosis Study Group. Treatment Protocol of the Second International HLH Study 2004. - HLH-2004
Barncancerforskningsenheten, Astrid Lindgrens Barnsjukhus0 个研究点目标入组 300 人开始时间: 2005年8月26日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •The diagnosis of HLH. All patients with this diagnosis will be offered the treatment protocol. All patients diagnosed with the disease for the first time are eligible for inclusion.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
招募中
不适用
A registry for hemophagocytic lymphohistiocytosis (HLH)hemophagocytic lymphohistiocytosis (HLH)D76.1Haemophagocytic lymphohistiocytosisDRKS00010148niversitätsklinikum FreiburgCentrum für Chronische Immundefizienz (CCI)300
招募中
不适用
Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE StudyLymphohistiocytosis, HemophagocyticSecondary Hemophagocytic LymphohistiocytosisMacrophage Activation SyndromeHyperinflammatory SyndromesNCT06339177National Institute of Allergy and Infectious Diseases (NIAID)300
终止
2 期
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLHHemophagocytic LymphohistiocytosesNCT03985423Swedish Orphan Biovitrum7
招募中
2 期
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)Secondary Hemophagocytic Lymphohistiocytosis (sHLH)NCT05416307Electra Therapeutics Inc.156
招募中
4 期
Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic LymphohistiocytosisHemophagocytic LymphohistiocytosesCytokine StormNCT05491304The Children's Hospital of Zhejiang University School of Medicine400